The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 02, 2019

Filed:

May. 21, 2015
Applicant:

University of Notre Dame Du Lac, Notre Dame, IN (US);

Inventors:

Zdenek Slouka, South Bend, IN (US);

Satyajyoti Senapati, Mishawaka, IN (US);

Sunny S. Shah, Mishawaka, IN (US);

Hsueh-Chia Chang, Granger, IN (US);

Assignee:

UNIVERSITY OF NOTRE DAME DU LAC, Notre Dame, IN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 27/447 (2006.01); G01N 27/333 (2006.01); G01N 33/487 (2006.01); B01L 3/00 (2006.01); G01N 27/327 (2006.01); G01N 1/40 (2006.01);
U.S. Cl.
CPC ...
G01N 33/48721 (2013.01); B01L 3/502753 (2013.01); G01N 27/3276 (2013.01); G01N 27/44743 (2013.01); G01N 27/44791 (2013.01); B01L 2300/0645 (2013.01); B01L 2300/0681 (2013.01); B01L 2400/0415 (2013.01); B01L 2400/0418 (2013.01); B01L 2400/0421 (2013.01); B01L 2400/0487 (2013.01); G01N 2001/4011 (2013.01);
Abstract

Disclosed are methods, compositions, and devices for an integrated, heterogenerous ion-exchange membrane-based plastic microfluidic biochip platform that can be used to detect multiple diagnostic markers present in real samples. Its various components can be easily integrated in a modular fashion for different applications. Automated control allows sequential and dynamic activation of different components on the chip. The integrated platform consists of three units and is designed to execute the following functions: (i) separation of the target biomolecules from the real sample, (ii) localizing and concentrating the targeted molecules at a specific location in the microfluidic chip, and (iii) detection of the targeted molecules using hybridization/docking events against a complementary ssDNA oligoprobe sequence or a specific antibody.


Find Patent Forward Citations

Loading…